New Contract for Colorado Based Medical Cannabis and Infused Product Facility Design and Operational Consulting
- June 28, 2016
- Posted by: Terry Buffalo
- Category: Uncategorized
|American Cannabis Company Inc. Announces New Contract for Colorado Based Medical Cannabis and Infused Product Facility Design and Operational Consulting|
DENVER, CO–(Marketwired – Jun 28, 2016) – American Cannabis Company, Inc. (OTCQB: AMMJ) (the “Company”), a full-service business-to-business consulting solutions provider, and seller of ancillary products to the cannabis industry, today announced it has secured a new design and consulting contract for the establishment of a Colorado based cannabis cultivation and infused products manufacturing facility.
The multi-phase project will begin with the construction of a greenhouse and infused products manufacturing facility. Future plans call for additional green houses as well as full sun cultivation. This combination establishes a foundation for sustainably-centered operations, and this presents the ability to rigorously compete in the already mature Colorado market.
Corey Hollister, president and CEO of American Cannabis Company, commented: “We are excited to be collaborating with our new client to establish these next generation operations. As markets mature and operators move to discover and implement methods to reduce cost, especially with the demand in the cannabis oil segment, greenhouse and full sun production will be natural progressions.”
About American Cannabis Company, Inc.:
For more information, please visit: www.americancannabiscompanyinc.com.
Forward Looking Statements
This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
|Communicate with management|
|Jun 28, 2016|